Author:
Park Se Hee,Ji Kon-Young,Park Seo Young,Kim Hyun Min,Ma Sang Hoon,Do Ju Hui,Kang Hyuno,Kang Hyung Sik,Oh Doo-Byoung,Shim Jae Sung,Joung Young Hee
Abstract
AbstractThe production of pharmacological vaccines in plants has been an important goal in the field of plant biotechnology. GA733-2, the protein that is also known as colorectal carcinoma (CRC)-associated antigen, is a strong candidate to produce a colorectal cancer vaccine. Tomato is the one of the major targets for production of an edible vaccine, as tomato is a fruit consumed in fresh form. It also contains high content of vitamins that aid activation of immune response. In order to develop an edible colorectal cancer vaccine, the transgene rGA733-Fc that encodes a fusion protein of GA733-2, the fragment crystallizable (Fc) domain, and the ER retention motif (rGA733-Fc) was introduced into tomato plants (Solanumlycopersicum cv. Micro-Tom). The transgenic plants producing rGA733-Fc (rGA733-FcOX) protein were screened based on stable integration of transgene expression cassette and expression level of rGA733-Fc protein. Further glycosylation pattern analysis revealed that plant derived rGA733-Fc protein contains an oligomannose glycan structure, which is a typical glycosylation pattern found on ER-processing proteins. The red fruits of rGA733-FcOX transgenic tomato plants containing approximately 270 ng/g FW of rGA733-Fc protein were orally administered to C57BL/6 mice. Oral administration of tomato fruits of the rGA733-Fc expressing transgenic plants delayed colorectal cancer growth and stimulated immune responses compared to oral administration of tomato fruits of the h-Fc expressing transgenic plants in the C57BL/6J mice. This is the first study showing the possibility of producing an edible colorectal cancer vaccine using tomato plants. This research would be helpful for development of plant-derived cancer edible vaccines.
Funder
New breeding technologies development Program, Rural Development Administration, Korea
Next-Generation BioGreen21 Program, Next-Generation BioGreen21 Program, Korea
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Foon, K. A. Immunotherapy for colorectal cancer. Curr. Oncol. Rep. 3, 116–126 (2001).
2. Im, S. S., Monk, B. J. & Villarreal, L. P. Prevention of cervical cancer with vaccines. Curr. Oncol. Rep. 3, 322–328 (2001).
3. Zeh, H. J., Stavely-O’Carroll, K. & Choti, M. A. Vaccines for colorectal cancer. Trends Mol. Med. 7, 307–313 (2001).
4. Morse, M. A., Gwin, W. R. 3rd. & Mitchell, D. A. Vaccine therapies for cancer: Then and now. Target Oncol. 16, 121–152 (2021).
5. Vermaelen, K. Vaccine strategies to improve anti-cancer cellular immune responses. Front. Immunol. 22, 10–18 (2019).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献